PixarBio Corporation (PXRB) es una empresa que cotiza en bolsa en el Consumo Cíclico sector, operando dentro de la Personal Products & Services industria. El CEO actual es Francis M. Reynolds.
PXRB tiene fecha de IPO 2023-06-27, 30 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $82.00.
PixarBio Corporation, a specialty pharmaceutical/biotechnology company, focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain. The company researches and develops delivery systems for drugs, devices, or biologics to treat pain, epilepsy, epilepsy, Parkinson's disease, and spinal cord injury. Its principal product platform is NeuroRelease for the therapeutic release of non-opiate drugs for post-operative, acute, and chronic pain in pre-clinical models. The company was founded in 2014 and is based in Medford, Massachusetts.
